News Voyageur Pharmaceuticals Ltd. Toronto S.E.

Equities

VM

CA92916K1057

Delayed Toronto S.E. Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		+7.14%	-.--%

Mar. 26	Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023	CI
Mar. 13	Voyageur Pharmaceuticals Ltd. Announces A Significant Advancement in Its Partnership with Rain Cage Carbon Inc	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors	Apr. 03	AQ
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options	Mar. 26	AQ
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023	Mar. 26	CI
Voyageur Pharmaceuticals Ltd. Announces A Significant Advancement in Its Partnership with Rain Cage Carbon Inc	Mar. 13	CI
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development	Mar. 13	AQ
Voyageur Pharmaceuticals Ltd. and Applied Pharmaceutical Innovation Sign Master Services Agreement	Mar. 04	CI
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement	Mar. 04	AQ
Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement	Mar. 01	AQ
Voyageur Pharmaceuticals Ltd. announced that it has received CAD 0.4885 million in funding	Feb. 29	CI
Voyageur Pharmaceuticals Ltd. announced that it expects to receive CAD 0.8 million in funding	Jan. 15	CI
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors	Dec. 21	AQ
Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule	Dec. 21	AQ
Voyageur Pharmaceuticals takes major step forward announcing international expansion	Dec. 18	AQ
Voyageur Pharmaceuticals Ltd. Announces the Formalization of A Pivotal Sales and Distribution Alliance	Dec. 14	CI
Voyageur Pharmaceuticals Initiates International Expansion	Dec. 14	AQ
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	23-10-30	CI
Voyageur Pharmaceuticals "sees a gap in the market" for domestically-produced barium	23-09-28	AQ
Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media	23-09-14	AQ
Voyageur Pharmaceuticals Ltd. Announces Board Changes	23-08-01	CI
Voyageur Pharmaceuticals Ltd. Announces Filing of Interim Financial Statements, Director Changes and Grant of Stock Options	23-08-01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Voyageur Pharmaceuticals Ltd. Toronto S.E.

Equities

VM

CA92916K1057

Summary

Filters